Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Basal Cell | 8 | 2024 | 560 | 1.320 |
Why?
|
Skin Neoplasms | 19 | 2024 | 5821 | 1.250 |
Why?
|
Mohs Surgery | 4 | 2020 | 222 | 0.910 |
Why?
|
Microscopy, Confocal | 14 | 2021 | 1971 | 0.830 |
Why?
|
Ink | 1 | 2019 | 47 | 0.640 |
Why?
|
Nails | 1 | 2020 | 296 | 0.620 |
Why?
|
Hutchinson's Melanotic Freckle | 3 | 2020 | 25 | 0.520 |
Why?
|
Carcinoma in Situ | 1 | 2020 | 791 | 0.480 |
Why?
|
Skin | 6 | 2020 | 4484 | 0.440 |
Why?
|
Preoperative Care | 1 | 2019 | 2242 | 0.360 |
Why?
|
Dermoscopy | 5 | 2021 | 66 | 0.350 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4024 | 0.240 |
Why?
|
Aminolevulinic Acid | 1 | 2024 | 144 | 0.220 |
Why?
|
Biopsy | 8 | 2021 | 6766 | 0.210 |
Why?
|
Tomography, Optical Coherence | 3 | 2020 | 2917 | 0.210 |
Why?
|
Melanoma | 4 | 2021 | 5709 | 0.190 |
Why?
|
Paget Disease, Extramammary | 1 | 2021 | 51 | 0.180 |
Why?
|
Neoplasm, Residual | 3 | 2019 | 1008 | 0.170 |
Why?
|
Surgical Tape | 1 | 2019 | 4 | 0.170 |
Why?
|
Photosensitizing Agents | 1 | 2024 | 623 | 0.170 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2020 | 35 | 0.170 |
Why?
|
Vulvar Neoplasms | 1 | 2021 | 263 | 0.150 |
Why?
|
Lasers, Gas | 1 | 2019 | 101 | 0.150 |
Why?
|
Photochemotherapy | 1 | 2024 | 823 | 0.150 |
Why?
|
Foot | 1 | 2020 | 575 | 0.130 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2020 | 328 | 0.130 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14665 | 0.130 |
Why?
|
Aged, 80 and over | 10 | 2024 | 58984 | 0.120 |
Why?
|
Hand | 1 | 2020 | 903 | 0.120 |
Why?
|
Feasibility Studies | 3 | 2020 | 5247 | 0.120 |
Why?
|
Ultraviolet Therapy | 1 | 2014 | 84 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2020 | 1530 | 0.100 |
Why?
|
Prospective Studies | 10 | 2024 | 54423 | 0.100 |
Why?
|
Laser Therapy | 1 | 2019 | 1092 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9280 | 0.090 |
Why?
|
Aged | 12 | 2024 | 169310 | 0.080 |
Why?
|
Image Enhancement | 1 | 2019 | 2884 | 0.080 |
Why?
|
Middle Aged | 12 | 2024 | 220921 | 0.070 |
Why?
|
Psoriasis | 1 | 2014 | 950 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11120 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2894 | 0.060 |
Why?
|
Male | 14 | 2024 | 360846 | 0.060 |
Why?
|
Injections, Jet | 1 | 2024 | 8 | 0.060 |
Why?
|
Female | 14 | 2024 | 392705 | 0.060 |
Why?
|
Humans | 20 | 2024 | 761596 | 0.060 |
Why?
|
Tumor Burden | 2 | 2020 | 1892 | 0.060 |
Why?
|
Adult | 8 | 2021 | 221210 | 0.050 |
Why?
|
Anthraquinones | 1 | 2020 | 41 | 0.050 |
Why?
|
Paper | 1 | 2019 | 84 | 0.040 |
Why?
|
Automation | 1 | 2021 | 586 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2019 | 573 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2020 | 1085 | 0.030 |
Why?
|
Physical Examination | 1 | 2021 | 1255 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2024 | 64685 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20100 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3597 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2020 | 80647 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8633 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39106 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 5971 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2578 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4652 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9469 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15266 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2014 | 12341 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29629 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23996 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15843 | 0.010 |
Why?
|
Concepts
(68)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_